Nanobiotix S.A.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Nanobiotix S.A.'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 529% to $30,058,000. The net income raised on -$39,700,000 and profit margin reached -132%. Total operating expenses were $56,837,000.

Profit Margin

Nanobiotix S.A. (NASDAQ:NBTX): Profit margin
2014 967.5K -9.55M -987.75%
2015 265.54K -17.00M -6403.14%
2016 1.55M -21.88M -1404.31%
2017 251.96K -26.14M -10375.62%
2018 116K -29.89M -25772.41%
2019 68K -50.91M -74875%
2020 50K -33.62M -67246%
2021 10K -47.00M -470040%
2022 4.77M -57.04M -1194.37%
2023 30.05M -39.7M -132.08%

NBTX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
30.05M4.77M10K50K68K116K251.96K1.55M265.54K967.5K
Cost of revenue
0985K0000345.59K0359.61K0
Gross profit
30.05M3.79M10K50K68K116K-93.62K1.55M-94.06K967.5K
Operating exp.
Research and development
38.39M32.63M30.37M24.33M30.41M20.89M16.33M16.91M13.90M8.07M
Selling and marketing
0000000000
Total operating expenses
56.83M46.70M47.17M36.53M46.84M30.18M25.51M23.41M17.40M10.58M
Operating income
-26.77M-46.70M-52.57M-36.42M-46.77M-30.06M-25.26M-21.85M-17.14M-9.61M
Other income (expenses), net
-12.80M-10.33M5.58M2.84M-4.13M-278K-876K-65.68K138.56K142.52K
Income before tax
-39.58M-57.03M-46.99M-33.61M-50.91M-30.34M-26.14M-21.79M-17.00M-9.47M
Income tax expense
120K10K5K9K3K-449K2090.42K37.57K79.27K
Net income
-39.7M-57.04M-47.00M-33.62M-50.91M-29.89M-26.14M-21.88M-17.00M-9.55M
Earnings per share
Basic EPS
-1.08-1.64-1.35-1.38-2.35-1.52-1.5-1.43-1.2-0.74
Diluted EPS
-1.08-1.64-1.35-1.38-2.35-1.52-1.5-1.43-1.2-0.74
Data sourceData sourceData sourceData source